Further evidence for an inhibition of hepatic gluconeogenesis in hypoglycemia due to non-insulin-productin tumors.
D001786:Blood Glucose / Q000378:metabolism; D002247:Carbon Isotopes; D006597:Fructose-Bisphosphatase / Q000378:metabolism; D005634:Fructose-Bisphosphate Aldolase / Q000378:metabolism; D005636:Fructosephosphates / Q000378:metabolism; D005941:Glucokinase / Q000378:metabolism; D005943:Gluconeogenesis / Q000187:drug effects*; D005947:Glucose / Q000378:metabolism; D005958:Glucosephosphates / Q000378:metabolism; D006593:Hexokinase / Q000378:metabolism; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology / Q000378:metabolism*; D008099:Liver / Q000187:drug effects; D008113:Liver Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009455:Neurofibroma / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D010732:Phosphofructokinase-1 / Q000378:metabolism; D011770:Pyruvate Kinase / Q000378:metabolism
D001786:Blood Glucose; D002247:Carbon Isotopes; D005636:Fructosephosphates; D005958:Glucosephosphates; D006593:Hexokinase; D010732:Phosphofructokinase-1; D005941:Glucokinase; D011770:Pyruvate Kinase; D006597:Fructose-Bisphosphatase; D005634:Fructose-Bisphosphate Aldolase; D005947:Glucose; D008775:Methylprednisolone